UiPath shares moved higher after the company joined a leading industry group focused on agent-based AI standards.

In the current session, UiPath Inc. (NYSE: PATH) is trading at $9.88, after a 2.23% decrease. Over the past month, the stock decreased by 30.01%, and in the past year, by 19.72%. With performance like ...

UiPath (PATH) has been one of the most searched-for stocks on Zacks.com lately. So, you might want to look at some of the facts that could shape the stock's performance in the near term. Over the past ...

UiPath (NYSE:PATH) introduced new AI tools for healthcare at the ViVE 2026 conference. The offerings include medical records summarization, claim denial prevention, and prior authorization support.

Why UiPath is on investors’ radar right now UiPath (PATH) has drawn fresh attention after recent share price moves, with the stock showing mixed short term performance and a deeper pullback over the ...

UiPath isn't down for the count, but it faces existential challenges.

UiPath has been bruised badly in recent years, but the latest quarter offers hope. As demand for agents and automation picks up, perhaps the Street-high price target of $17 is due for a hike. Follow ...

ChatGPT thinks UiPath stock could drift lower over the next 60 days, projecting a move toward roughly $16.20 by late March as technical momentum weakens. Investors looking to express that view without ...

TD Cowen lowered the firm’s price target on UiPath (PATH) to $12 from $16 and keeps a Hold rating on the shares. The firm said the US administration change/DOGE dynamics and broader macro uncertainty ...

The P/E ratio measures the current share price to the company's EPS. It is used by long-term investors to analyze the company's current performance against it's past earnings, historical data and ...

The average one-year price target for UiPath (NYSE:PATH) has been revised to $15.99 / share. This is an increase of 15.84% from the prior estimate of $13.80 dated November 14, 2025. The price target ...